Search for Clinical Trial Results

Sponsored By

Bourneville Syndrome - 25 Studies Found

Status Study
Completed Study Name: Tuberous Sclerosis Complex Natural History Study: Renal Manifestations
Condition: Tuberous Sclerosis Complex
Date: 2007-12-27
Recruiting Study Name: A Study of Everolimus in the Treatment of Neurocognitive Problems in Tuberous Sclerosis
Condition: Tuberous Sclerosis
Date: 2013-09-05
Interventions:
  • Drug: Placebo 5mg daily admini
Active, not recruiting Study Name: Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
Condition: Tuberous Sclerosis Complex
Date: 2013-01-28
Completed Study Name: Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC)
Condition: Tuberous Sclerosis Complex
Date: 2011-02-02
Interventions: Drug: RAD001 RAD001 is formulated as tablets of 5.0 mg str
Recruiting Study Name: Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex
Condition: Tuberous Sclerosis Complex
Date: 2016-02-10
Interventions: Behavioral: JASPER JASPER (Joint Attention, Symbolic Play, Engagement, and Regulation) is a treatment ap
Recruiting Study Name: Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex
Condition: Tuberous Sclerosis Complex
Date: 2016-07-13
Interventions:
  • Drug: Vigabatrin Subjects rand
Recruiting Study Name: Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France
Condition: Tuberous Sclerosis Complex
Date: 2016-08-30
Completed Study Name: Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM
Condition:
  • Tuberous Sclerosis
  • Lymphangioleiomyomatosis

Date: 2007-04-06
Interventions: Drug: Rapamycin, sirolimus
Recruiting Study Name: Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers
Condition:
  • Renal Angiomyolipomas
  • Tuberous Sclerosis

Date: 2014-04-01
Interventions: Drug: Propranolol
Completed Study Name: Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex
Condition:
  • Tuberous Sclerosis
  • Subependymal Giant Cell Astrocytoma
    • Date: 2006-12-12
    Interventions: Drug: Everolimus Initial everolimus dosage will be 3 mg/m2/d taken daily or every other day, with titrat
Next >>>